Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy C Brahm

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Primary Care Companion to the Journal of Clinical Psychiatry|October 16, 2007
Risperidone and Dysphagia in a developmentally disabled womanNancy C Brahm, Gary A Fast, Robert C Brown
International Journal of Endocrinology and Metabolism|July 16, 2013
Evaluation of serum prolactin levels in intellectually disabled patients using antipsychotic medicationsTammy L Lambert, Kevin C Farmer, Nancy C Brahm
Journal of Clinical Psychopharmacology|June 27, 2003
Assessment of QTc prolongation following thioridazine withdrawal in a developmentally disabled populationNancy C Brahm, Arthur Buswell, Dix Christensen, et al.
Research in Social & Administrative Pharmacy : RSAP|December 21, 2013
National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warningManish Mittal, Donald L Harrison, Michael J Miller, et al.
The Annals of Pharmacotherapy|July 15, 2004
Thyroid function alterations following quetiapine initiation in a developmentally disabled adolescentRichard L Dobbs, Nancy C Brahm, Gary Fast, et al.
Journal of Pharmacy Practice|August 17, 2011
Probable quetiapine-mediated prolongation of the QT intervalNasim Aghaienia, Nancy C Brahm, Kyla M Lussier, et al.
International Journal of Clinical Pharmacy|March 4, 2016
Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depressionAmany K Hassan, Kevin C Farmer, Nancy C Brahm, et al.
The Annals of Pharmacotherapy|July 1, 2004
Protozoal infections in the developmentally disabled: often overlooked cause of rectal digging and fecal smearingNancy C Brahm, Arthur L Buswell, Rebecca E Brahm, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2010
Commonly prescribed medications and potential false-positive urine drug screensNancy C Brahm, Lynn L Yeager, Mark D Fox, et al.
The Annals of Pharmacotherapy|May 16, 2013
Mental health treatment associated with community-based depression screening: considerations for planning multidisciplinary collaborative careBruce R Winchester, Sarah C Watkins, Nancy C Brahm, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Primary Care Companion to the Journal of Clinical Psychiatry|October 16, 2007
Risperidone and Dysphagia in a developmentally disabled womanNancy C Brahm, Gary A Fast, Robert C Brown
International Journal of Endocrinology and Metabolism|July 16, 2013
Evaluation of serum prolactin levels in intellectually disabled patients using antipsychotic medicationsTammy L Lambert, Kevin C Farmer, Nancy C Brahm
Journal of Clinical Psychopharmacology|June 27, 2003
Assessment of QTc prolongation following thioridazine withdrawal in a developmentally disabled populationNancy C Brahm, Arthur Buswell, Dix Christensen, et al.
Research in Social & Administrative Pharmacy : RSAP|December 21, 2013
National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warningManish Mittal, Donald L Harrison, Michael J Miller, et al.
The Annals of Pharmacotherapy|July 15, 2004
Thyroid function alterations following quetiapine initiation in a developmentally disabled adolescentRichard L Dobbs, Nancy C Brahm, Gary Fast, et al.
Journal of Pharmacy Practice|August 17, 2011
Probable quetiapine-mediated prolongation of the QT intervalNasim Aghaienia, Nancy C Brahm, Kyla M Lussier, et al.
International Journal of Clinical Pharmacy|March 4, 2016
Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depressionAmany K Hassan, Kevin C Farmer, Nancy C Brahm, et al.
The Annals of Pharmacotherapy|July 1, 2004
Protozoal infections in the developmentally disabled: often overlooked cause of rectal digging and fecal smearingNancy C Brahm, Arthur L Buswell, Rebecca E Brahm, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2010
Commonly prescribed medications and potential false-positive urine drug screensNancy C Brahm, Lynn L Yeager, Mark D Fox, et al.
The Annals of Pharmacotherapy|May 16, 2013
Mental health treatment associated with community-based depression screening: considerations for planning multidisciplinary collaborative careBruce R Winchester, Sarah C Watkins, Nancy C Brahm, et al.
Pageof 4